Arkolith/Insider Trading/ROIV/Form 4

Torti Frank

President and Vant ChairRoivant Sciences Ltd. (ROIV) · full profile →Form 4 · filed Feb 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$82.0M
Net Open-Market Flow
-$82.0M
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 23, 2026Option exercise(M)587K$3.85$2.3M14.3M
Feb 23, 2026Sell(S)587K$27.51$16.2M13.7M
Feb 20, 2026Option exercise(M)1.0M$3.85$3.9M14.7M
Feb 20, 2026Sell(S)1.0M$27.15$27.5M13.7M
Feb 19, 2026Option exercise(M)1.4M$3.85$5.4M15.1M
Feb 19, 2026Sell(S)1.4M$27.42$38.4M13.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 23, 2026Option exercise(M)587K—$03.0M
Feb 20, 2026Option exercise(M)1.0M—$03.6M
Feb 19, 2026Option exercise(M)1.4M—$04.6M

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001635088-26-000019) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML